Awards Grant Combination therapy to improve on CuATSM outcomes in ALS Prion-like strains of TDP-43 aggregates in MND and FTLD Using patient derived cells to define an electrical signature of sporadic ALS and to develop a high throughput drug screening technology and novel therapy
